share_log

Piper Sandler Downgrades Achilles Therapeutics to Neutral, Lowers Price Target to $2

Moomoo 24/7 ·  Apr 5 06:32

Piper Sandler analyst Joseph Catanzaro downgrades Achilles Therapeutics (NASDAQ:ACHL) from Overweight to Neutral and lowers the price target from $8 to $2.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment